ERBB2 and breast neoplasm: Santos et al [8] analyzed the ERBB2 protein (both, ICD and ECD) and the RNA levels of the ICD coding region of ERBB2. In this work it was reported that ERBB2 is frequently downregulated in FMT, proposing it as a valuable model for ERBB2 negative breast tumors.